Screen Readers Skip to Content
Tweet Facebook Email
Print Page

National Meningitis Association Statement on Advisory Committee on Immunization Practices Vote

Author: National Meningitis Association

Published: Thursday, 28th October 2010 (9 years ago) - Updated: Thursday, 28th October 2010 (9 years ago) .

Synopsis:

Expanding adolescent meningococcal vaccination recommendation to include a booster.

Main Digest

On October 27, 2010, the CDC's Advisory Committee on Immunization Practices (ACIP) voted to expand the adolescent meningococcal vaccination recommendation to include a booster.

Routine vaccination at age 11-12 years continues to be recommended with a booster dose at age 16.

For adolescents who are first vaccinated between 13 and 15 years of age, a booster dose is recommended 5 years after the first dose through age 21.

NMA Statement:

The National Meningitis Association supports ACIP's decision to maintain meningococcal immunization at age 11-12 and to add a booster dose to provide increased prevention of disease among adolescents throughout their high-risk years.

This is a good public health decision that will protect our children from meningococcal disease.

We looked forward to supporting this recommendation as well as the adolescent immunization platform through our education and outreach programs.

Similar Documents

For further related information see our full list of Immunization Documents.

If you use an RSS feed reader you are welcome to subscribe to our latest Immunization publications.

Important Disclaimer:
Disabled World is strictly a news and information website provided for general informational purpose only and does not constitute medical advice. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World.

Please report 📧 outdated or inaccurate information to us.